Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07322172 · ClinicalTrials.gov registry record · NA

Pilot Study of Patient Navigation for Kidney Stone Patients After ED Visits

A NA study, sponsored by University of California, San Francisco.

Not yet
Registry status
NA
Development phase
31
Enrollment target

NCT07322172: Clinical Trial NA study, sponsored by University of California, San Francisco.

NCT07322172 is a NA study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07322172, a NA study, has not yet begun recruiting, sponsored by University of California, San Francisco.

NOT YET RECRUITING
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

Patients who visit the emergency department for kidney stones are sometimes referred to urology for follow-up care but never complete that visit. Missing follow-up appointments can lead to worse outcomes, including recurrent pain, infection, or surgery. Research shows that patients who are socially or economically at risk (such as those with public insurance, lower income, or limited English proficiency) are more likely to experience these care gaps. This study will pilot a patient navigation program designed to help patients with urinary stone disease (USD) attend their scheduled urology appointments after being seen in the Emergency Department. Using an electronic health record (EHR) based prediction model developed in earlier research, patients at higher risk for being lost to follow-up will be identified and invited to participate. Each participant will be paired with a trained patient navigator who will assess barriers to care, provide support, and maintain contact for about 12 weeks. The goal of this study is to evaluate the outcomes and feasibility of this navigation intervention. Findings will help determine whether a larger study should test if this approach improves access to care and health outcomes for patients with kidney stones.

Interventions

  • OTHER Patient Navigation

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2026-07
Est. Completion 2026-07
Phase NA

What is known before NCT07322172 opens enrollment

NCT07322172 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Patient Navigation is the first listed.

NCT07322172 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07322172 about?

NCT07322172 is a clinical study titled "Pilot Study of Patient Navigation for Kidney Stone Patients After ED Visits". Patients who visit the emergency department for kidney stones are sometimes referred to urology for follow-up care but never complete that visit. Missing follow-up appointments can lead to worse outcomes, including recurrent pain, infection, or surgery. Research shows that patients who are socially ...

What is the current status of trial NCT07322172?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 31 participants. The study started on 2026-07. Estimated completion is 2026-07.

What interventions are being tested in trial NCT07322172?

The interventions under investigation include: Patient Navigation (OTHER).

Who is sponsoring clinical trial NCT07322172?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07322172's enrollment target sits among peer trials

31 1592nd of 2000 higher than 408 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07322172, the US trial registry maintained by the National Library of Medicine. NCT07322172 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.